Bramlage, Peter http://orcid.org/0000-0003-4970-2110
Tittel, Sascha R. http://orcid.org/0000-0001-7913-6135
Müther, Silvia
Reinhart-Steininger, Birgit
Haberland, Holger
Khodaverdi, Semik
Zimny, Stefan
Ohlenschläger, Ute
Lanzinger, Stefanie http://orcid.org/0000-0002-3789-6459
Haak, Thomas
Funding for this research was provided by:
Sanofi
Article History
Received: 11 January 2022
Accepted: 3 July 2022
First Online: 7 August 2022
Declarations
:
: PB reports to have received consultancy honoraria from Sanofi and Abbott. TH reports to have received consultancy honoraria from Novo Nordisk, Lilly, Sanofi, MSD, Abbott, Boehringer Ingelheim, Dexcom, and Bayer. The other authors declare that they have no conflict of interest.
: The DPV initiative, which was established in 1995, was approved by the ethics committee of the University of Ulm, and data collection was approved by local review boards.
: Informed consent was obtained from all participants before enrollment.